Sfoglia per Autore
Divergent modulation of neuronal differentiation by caspase-2 and -9.
2012-05-01 Pistritto, G; Papaleo, V; Sanchez, P; Ceci, C; Barbaccia, Ml
Targeting COX-2/PGE(2) pathway in HIPK2 knockdown cancer cells: impact on dendritic cell maturation.
2012-11-01 Garufi, A; Pistritto, G; Ceci, C; Di Renzo, L; Santarelli, R; Faggioni, A; Cirone, M; D'Orazi, G
Effect of nickel exposure on neuronal differentiation
2013-01-01
"Microsfere di idrogeli di polimeri polisaccaridici contenenti cellule neurali secernenti dopamina, procedimento per la /01'0 preparazione e loro usi in campo medico"
2013-10-18 Pistritto, G; Bianco, A; Cacciotti, I; Ceci, C
A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib
2015-01-01 Graziani, G; Artuso, S; De Luca, A; Muzi, A; Rotili, D; Scimeca, M; Atzori, M; Ceci, C; Mai, A; Leonetti, C; Levati, L; Bonanno, E; Tentori, L; Caccuri, Am
A not cytotoxic nickel concentration alters the expression of neuronal differentiation markers in NT2 cells
2015-01-19 Ceci, C; Barbaccia, Ml; Pistritto, G
Ellagic acid inhibits bladder cancer invasiveness and in vivo tumor growth
2016-01-01 Ceci, C; Tentori, L; Atzori, Mg; Lacal, P; Bonanno, E; Scimeca, M; Cicconi, R; Mattei, M; De Martino, M; Vespasiani, G; Miano, R; Graziani, G
Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies
2016-01-01 Pistritto, G; Trisciuoglio, D; Ceci, C; Alessia, G; D'Orazi, G
The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells
2017-01-01 Atzori, Mg; Tentori, L; Ruffini, F; Ceci, C; Lisi, L; Bonanno, E; Scimeca, M; Eskilsson, E; Daubon, T; Miletic, H; Ricci Vitiani, L; Pallini, R; Navarra, P; Bjerkvig, R; D'Atri, S; Lacal, Pm; Graziani, G
Neuro-differentiated Ntera2 cancer stem cells encapsulated in alginate beads: First evidence of biological functionality
2017-12-01 Cacciotti, I; Ceci, C; Bianco, A; Pistritto, G
Experimental evidence of the antitumor, antimetastatic and antiangiogenic activity of ellagic acid
2018-01-01 Ceci, C; Lacal, Pm; Tentori, L; De Martino, Mg; Miano, R; Graziani, G
The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo.
2018-01-01 Atzori, Mg; Tentori, L; Ruffini, S; Ceci, C; Bonanno, E; Scimeca, M; Lacal, P; Graziani, G
Strategies to improve ellagic acid bioavailability: from natural or semisynthetic derivatives to nanotechnological approaches based on innovative carriers
2020-01-01 Ceci, C; Graziani, G; Faraoni, I; Cacciotti, I
Role of VEGFs/VEGFR-1 signaling and its inhibition in modulating tumor invasion: experimental evidence in different metastatic cancer models
2020-01-01 Ceci, C; Atzori, Mg; Lacal, Pm; Graziani, G
Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib
2020-01-01 Atzori, Mg; Ceci, C; Ruffini, F; Trapani, M; Barbaccia, Ml; Tentori, L; D'Atri, S; Lacal, Pm; Graziani, G
Targeting tumor-associated macrophages to increase the efficacy of immune checkpoint inhibitors: a glimpse into novel therapeutic approaches for metastatic melanoma
2020-01-01 Ceci, C; Atzori, Mg; Lacal, Pm; Graziani, G
Antibody-drug conjugates: resurgent anticancer agents with multi-targeted therapeutic potential
2022-01-01 Ceci, C; Lacal, Pm; Graziani, G
The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor
2022-11-14 Atzori, Mg; Ceci, C; Ruffini, F; Scimeca, M; Cicconi, R; Mattei, M; Lacal, Pm; Graziani, G
Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review
2023-01-01 Garcia-Chico, C; Lopez-Ortiz, S; Penin-Grandes, S; Pinto-Fraga, J; Valenzuela, Pl; Emanuele, E; Ceci, C; Graziani, G; Fiuza-Luces, C; Lista, S; Lucia, A; Santos-Lozano, A
Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors
2023-04-29 Ruffini, F; Ceci, C; Atzori, Mg; Caporali, S; Levati, L; Bonmassar, L; Cappellini, Gca; D'Atri, S; Graziani, G; Lacal, Pm
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-mag-2012 | Divergent modulation of neuronal differentiation by caspase-2 and -9. | Pistritto, G; Papaleo, V; Sanchez, P; Ceci, C; Barbaccia, Ml | Articolo su rivista | |
| 1-nov-2012 | Targeting COX-2/PGE(2) pathway in HIPK2 knockdown cancer cells: impact on dendritic cell maturation. | Garufi, A; Pistritto, G; Ceci, C; Di Renzo, L; Santarelli, R; Faggioni, A; Cirone, M; D'Orazi, G | Articolo su rivista | |
| 1-gen-2013 | Effect of nickel exposure on neuronal differentiation | - | Tesi di dottorato | |
| 18-ott-2013 | "Microsfere di idrogeli di polimeri polisaccaridici contenenti cellule neurali secernenti dopamina, procedimento per la /01'0 preparazione e loro usi in campo medico" | Pistritto, G; Bianco, A; Cacciotti, I; Ceci, C | Brevetti | |
| 1-gen-2015 | A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib | Graziani, G; Artuso, S; De Luca, A; Muzi, A; Rotili, D; Scimeca, M; Atzori, M; Ceci, C; Mai, A; Leonetti, C; Levati, L; Bonanno, E; Tentori, L; Caccuri, Am | Articolo su rivista | |
| 19-gen-2015 | A not cytotoxic nickel concentration alters the expression of neuronal differentiation markers in NT2 cells | Ceci, C; Barbaccia, Ml; Pistritto, G | Articolo su rivista | |
| 1-gen-2016 | Ellagic acid inhibits bladder cancer invasiveness and in vivo tumor growth | Ceci, C; Tentori, L; Atzori, Mg; Lacal, P; Bonanno, E; Scimeca, M; Cicconi, R; Mattei, M; De Martino, M; Vespasiani, G; Miano, R; Graziani, G | Articolo su rivista | |
| 1-gen-2016 | Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies | Pistritto, G; Trisciuoglio, D; Ceci, C; Alessia, G; D'Orazi, G | Articolo su rivista | |
| 1-gen-2017 | The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells | Atzori, Mg; Tentori, L; Ruffini, F; Ceci, C; Lisi, L; Bonanno, E; Scimeca, M; Eskilsson, E; Daubon, T; Miletic, H; Ricci Vitiani, L; Pallini, R; Navarra, P; Bjerkvig, R; D'Atri, S; Lacal, Pm; Graziani, G | Articolo su rivista | |
| 1-dic-2017 | Neuro-differentiated Ntera2 cancer stem cells encapsulated in alginate beads: First evidence of biological functionality | Cacciotti, I; Ceci, C; Bianco, A; Pistritto, G | Articolo su rivista | |
| 1-gen-2018 | Experimental evidence of the antitumor, antimetastatic and antiangiogenic activity of ellagic acid | Ceci, C; Lacal, Pm; Tentori, L; De Martino, Mg; Miano, R; Graziani, G | Articolo su rivista | |
| 1-gen-2018 | The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo. | Atzori, Mg; Tentori, L; Ruffini, S; Ceci, C; Bonanno, E; Scimeca, M; Lacal, P; Graziani, G | Articolo su rivista | |
| 1-gen-2020 | Strategies to improve ellagic acid bioavailability: from natural or semisynthetic derivatives to nanotechnological approaches based on innovative carriers | Ceci, C; Graziani, G; Faraoni, I; Cacciotti, I | Articolo su rivista | |
| 1-gen-2020 | Role of VEGFs/VEGFR-1 signaling and its inhibition in modulating tumor invasion: experimental evidence in different metastatic cancer models | Ceci, C; Atzori, Mg; Lacal, Pm; Graziani, G | Articolo su rivista | |
| 1-gen-2020 | Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib | Atzori, Mg; Ceci, C; Ruffini, F; Trapani, M; Barbaccia, Ml; Tentori, L; D'Atri, S; Lacal, Pm; Graziani, G | Articolo su rivista | |
| 1-gen-2020 | Targeting tumor-associated macrophages to increase the efficacy of immune checkpoint inhibitors: a glimpse into novel therapeutic approaches for metastatic melanoma | Ceci, C; Atzori, Mg; Lacal, Pm; Graziani, G | Articolo su rivista | |
| 1-gen-2022 | Antibody-drug conjugates: resurgent anticancer agents with multi-targeted therapeutic potential | Ceci, C; Lacal, Pm; Graziani, G | Articolo su rivista | |
| 14-nov-2022 | The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor | Atzori, Mg; Ceci, C; Ruffini, F; Scimeca, M; Cicconi, R; Mattei, M; Lacal, Pm; Graziani, G | Articolo su rivista | |
| 1-gen-2023 | Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review | Garcia-Chico, C; Lopez-Ortiz, S; Penin-Grandes, S; Pinto-Fraga, J; Valenzuela, Pl; Emanuele, E; Ceci, C; Graziani, G; Fiuza-Luces, C; Lista, S; Lucia, A; Santos-Lozano, A | Articolo su rivista | |
| 29-apr-2023 | Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors | Ruffini, F; Ceci, C; Atzori, Mg; Caporali, S; Levati, L; Bonmassar, L; Cappellini, Gca; D'Atri, S; Graziani, G; Lacal, Pm | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile